Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LIPEGFILGRASTIM vs LOFEXIDINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LIPEGFILGRASTIM vs LOFEXIDINE: Safety Overview

Metric LIPEGFILGRASTIM LOFEXIDINE
Total FAERS Reports 425 139
Deaths Reported 41 0
Death Rate 9.6% N/A
Hospitalizations 248 17
Average Patient Age 56.4 yrs 47.5 yrs
% Female Patients 50.0% 51.8%
FDA Approval Date N/A Aug 20, 2024
Manufacturer N/A Prasco Laboratories
Route N/A ORAL
Marketing Status N/A Prescription